Keywords: CRPC، سرطان پروستات مقاوم به کاستراسیون; ADT, androgen deprivation therapy; AR, androgen receptor; CRPC, castration-resistant prostate cancer; DHT, dihydrotestosterone; HR, high-risk disease; MS, mass spectrometry; T, testosterone
مقالات ISI CRPC، سرطان پروستات مقاوم به کاستراسیون (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: CRPC، سرطان پروستات مقاوم به کاستراسیون; ADT, androgen deprivation therapy; BPH, benign prostatic hyperplasia; CCL2, CC chemokine ligand 2; CRPC, castration-resistant prostate cancer; EMT, epithelial mesenchymal transition; IGF-IR, insulin-like growth factor I receptor; IL, interleukin; MDSCs, m
Castration-Resistant Prostate Cancer: AUA Guideline Amendment 2015
Keywords: CRPC، سرطان پروستات مقاوم به کاستراسیون; prostatic cancer, castration-resistant; androgen antagonist; drug therapyADT, androgen deprivation therapy; AR, androgen receptor; ASCO, American Society of Clinical Oncology; CRPC, castration-resistant prostate cancer; FDA, U. S. Food and Drug Administra
Effects of microRNA-221/222 on cell proliferation and apoptosis in prostate cancer cells
Keywords: CRPC، سرطان پروستات مقاوم به کاستراسیون; CRPC, castration-resistant prostate cancer; miRNA or miR, microRNA; NGF, nerve growth factor; ERK1/2, extracellular signal-regulated kinase 1 and 2; ATCC, American Type Culture Collection; FBS, fetal bovine serum; 3′-UTR, 3′ untranslated region; PI, propi
Sensitization to docetaxel in prostate cancer cells by green tea and quercetin
Keywords: CRPC، سرطان پروستات مقاوم به کاستراسیون; AR, androgen receptor; AI, androgen-independent; ATP, adenosine triphosphate; CRPC, castration-resistant prostate cancer; GT, green tea; GTPs, green tea polyphenols; EGCG, (−)-epigallocatechin-3-gallate; FBS, fetal bovine serum; MRP, multidrug resistance-
CYP17A1 inhibitors in castration-resistant prostate cancer
Keywords: CRPC، سرطان پروستات مقاوم به کاستراسیون; AA, abiraterone acetate; ADT, androgen deprivation therapy; CRPC, castration-resistant prostate cancer; PCa, prostate cancerAbiraterone; Castration resistance; Prostate cancer
Castration-Resistant Prostate Cancer: AUA Guideline Amendment
Keywords: CRPC، سرطان پروستات مقاوم به کاستراسیون; prostatic neoplasms; radium; radiopharmaceuticalsAR, androgen receptor; CRPC, castration-resistant prostate cancer; ECOG, Eastern Cooperative Oncology Group; mCRPC, metastatic castration-resistant prostate cancer; OS, overall survival; PFS, progression-fr
Sequencing new agents after docetaxel in patients with metastatic castration-resistant prostate cancer
Keywords: CRPC، سرطان پروستات مقاوم به کاستراسیون; ABI, abiraterone; ADT, adrogen deprivation therapy; CABA, cabazitaxel; CRPC, castration-resistant prostate cancer; ENZA, enzalutamide; LDH, lactate dehydrogenase; ALP, alkaline phosphatase; Hb, hemoglobin; mCRPRC, metastatic castration-resistant prostate
Structurally flexible triethanolamine-core poly(amidoamine) dendrimers as effective nanovectors to deliver RNAi-based therapeutics
Keywords: CRPC، سرطان پروستات مقاوم به کاستراسیون; Ago2, Argonaute 2; AIDS, acquired immunodeficiency syndrome; CRPC, castration-resistant prostate cancer; dsiRNA, Dicer substrate siRNA; G, generation; GMP, good manufacture practice; GSC, glioblastoma stem cells; HAART, highly active antiretroviral therap
c-Jun NH2-terminal kinase-induced proteasomal degradation of c-FLIPL/S and Bcl2 sensitize prostate cancer cells to Fas- and mitochondria-mediated apoptosis by tetrandrine
Keywords: CRPC، سرطان پروستات مقاوم به کاستراسیون; ASK1, apoptosis signal-regulating kinase 1; Bax, Bcl2-associated X protein; Bcl2, B-cell lymphoma 2; Bid, BH3 interacting-domain death agonist; CRPC, castration-resistant prostate cancer; DAPI, 4′,6-diamidino-2-phenylindole; DHE, dihydroethidium; DISC, de
The Met receptor tyrosine kinase: A key player in oncogenesis and drug resistance
Keywords: CRPC، سرطان پروستات مقاوم به کاستراسیون; Met; HGF; Biomarker; Drug resistance; Precision medicine; Targeted therapyALK, Anaplastic lymphoma kinase; AML, Acute myeloid leukemia; Bid, Twice daily; CI, Confidence interval; CRPC, Castration-resistant prostate cancer; CSC, Cancer stem cell; DCR, Dise
Androgen receptor splice variants are resistant to inhibitors of Hsp90 and FKBP52, which alter androgen receptor activity and expression
Keywords: CRPC، سرطان پروستات مقاوم به کاستراسیون; PCa, prostate cancer; AR, androgen receptor; CRPC, castration-resistant prostate cancer; Hsp, heat shock proteins; DMSO, dimethyl sulfoxide; EtOH, ethanol; GA, geldanamycinAndrogen receptor (AR); Prostate cancer; Splice variants; Hsp90; FKBP52
Castration-Resistant Prostate Cancer: AUA Guideline
Keywords: CRPC، سرطان پروستات مقاوم به کاستراسیون; prostatic neoplasms; androgen antagonists; drug therapy; immunotherapyADT, androgen deprivation therapy; CRPC, castration-resistant prostate cancer; FDA, Food and Drug Administration; H&P, history and physical; mCRPC, metastatic castration-resistant prost
Transcriptional activity of c-Jun is critical for the suppression of AR function
Keywords: CRPC، سرطان پروستات مقاوم به کاستراسیون; AP-1, activator protein 1; CRPC, castration-resistant prostate cancer; DBD, DNA-binding domain; ARE, androgen-response element; DHT, dihydrotestosterone; bZIP, basic region leucine zipper; TRE, TPA-responsive elements; CRE, cyclic AMP-responsive elements;
Manipulating the epigenome for the treatment of urological malignancies
Keywords: CRPC، سرطان پروستات مقاوم به کاستراسیون; CRPC, castration-resistant prostate cancer; DNMT, DNA methyltransferase; DNMTi, DNA methyltransferase inhibitors; HDAC, histone deacetylase; HDACi, histone deacetylation inhibitors; PSA, prostate specific antigen; RCC, renal cell carcinoma; TCC, transitio
Effect of a novel 17,20-lyase inhibitor, orteronel (TAK-700), on androgen synthesis in male rats
Keywords: CRPC، سرطان پروستات مقاوم به کاستراسیون; 17-OHP, 17-hydroxyprogesterone; ACTH, adrenocorticotropic hormone; AUC, area under the plasma concentration time curve; BA, bioavailability; CI, confidence interval; Cmax, maximum plasma concentration; CRPC, castration-resistant prostate cancer; DHEA, deh
Design, synthesis, and biological evaluation of 3-aryl-3-hydroxy-1-phenylpyrrolidine derivatives as novel androgen receptor antagonists
Keywords: CRPC، سرطان پروستات مقاوم به کاستراسیون; PC, prostate cancer; AR, androgen receptor; CRPC, castration-resistant prostate cancer; CAB, combined androgen blockade; PSA, prostate-specific antigen; DHT, dihydrotestosterone; SAR, structure–activity relationship; EDC, N-[3-(dimethylamino)propyl]-N′-et
Hypoxia enhances transcriptional activity of androgen receptor through hypoxia-inducible factor-1α in a low androgen environment
Keywords: CRPC، سرطان پروستات مقاوم به کاستراسیون; AR, androgen receptor; ARE, androgen response element; CRPC, castration-resistant prostate cancer; C-TAD, C-terminal transactivation domain; DHT, 5α-dihydrotestosterone; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; HIF-1, hypoxia-inducible factor-1; H